Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 12/2/2024UCB Closes Divestment from Neurology and Allergy Portfolio in China, ...
  • 12/2/2024Allink Biotherapeutics Secures $42M Series A to Advance Oncology and I...
  • 12/2/2024Hangzhou Jiuyuan Gene Engineering Debuts on Hong Kong Stock Exchange
  • 12/2/2024Merck's Recarbrio Approved in China for Severe Bacterial Pneumonia
  • 12/2/2024Minghui Pharma Reports Positive Phase III Results for MH004 in Atopic ...
  • 12/2/2024Shanghai Cell Therapy Group Submits Application Proof for Hong Kong Li...
  • 12/2/2024Affinity Biopharma Raises Over CNY 400M in Series B2 to Advance Tumor-...
  • 12/2/2024Zambon's Xadago (Safinamide) Gains Chinese Approval for Parkinson's Di...
  • 12/2/2024Nanjing Leads Biolabs Files for Hong Kong IPO
  • 12/2/2024Miracogen to Present Phase II Data on MRG003 at ESMO Asia 2024  
  • 12/2/2024Hua Medicine Announces Successful H.K. SENSITIZE Study Results at the ...
  • 12/2/2024Everest Medicines Announces Acceptance of VELSIPITY NDA in Hong Kong
  • 11/29/2024Recent Executive Moves
  • 11/28/2024AstraZeneca's Enhertu Secures Reimbursement Listing Despite Ongoing Pr...
  • 11/28/2024BeOne Secures EU Approval for First-Line Checkpoint Blocker
  • 11/28/2024NMPA Solicits Public Comments on the Provisions for the Record Filing ...
  • 11/28/2024NHSA and MOHRSS Announce the 2024 National Drug Reimbursement List
  • 11/28/2024NHSA Issues Guidelines for Managing Pricing Risks of Shortage Drugs
  • 11/27/2024China Introduces New Policy to Strengthen Hierarchical Medical Care an...
  • 11/27/2024NHSA: Policies in Development to Synchronize Medical Insurance Funds a...
  • 11/27/2024Policy Change Set to Advance Cell and Gene Therapy in China
  • 11/27/2024CMS's CMS-D005 Gets Green Light for Its Obesity Drug Trials in China
  • 11/27/2024NMPA Accepts Akeso's sNDA for Penpulimab Plus Anlotinib for Advanced H...
  • 11/27/2024Hengrui Initiates Clinical Trial for SHR-1826, a c-Met ADC Drug
  • 11/27/2024Kelun's Merck-partnered TROP2 ADC sac-TMT Approved for Marketing in C...
  • 11/27/2024ChP Commission Approves Chinese Pharmacopeia 2025
  • 11/26/2024Snapshot of BMI System Financial Performance in 3Qs/2024
  • 11/25/2024China's Real-World Data Pilot Drives Global Collaboration and Regulato...
  • 11/25/2024DP Tech and Lepu Biopharma Enter ADC Partnership
  • 11/25/2024Rui Thera Present Clinical Trial Results of CD19 CAR NK Cell Therapy i...
  • Page:8/42 Total number of articles:1245: [First][<<] [6] [7] [8] [9] [10] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group